Shanghai Healthcare M&A Fund Strategically Acquires Chengdu Kanghua Biological, Establishing a Fully Integrated Ecosystem
HONG KONG SAR - Media OutReach Newswire - 21 July 2025 - Chengdu Kanghua Biological Products Co., Ltd. (Stock Code: 300841.SZ) announced that Shanghai Healthcare M&A Fund ("the M&A Fund") intends to acquire the Company through a strategic agreement. Leveraging its substantial resource and financial strength, the M&A Fund plans to support Kanghua Biological's established product portfolio, accelerate sales of its mature products, and develop industry synergies between Shanghai and Chengdu. The goal is to rapidly expand a diversified vaccine pipeline and build an integrated vaccine ecosystem that combines proven commercialized products with best-in-class R&D capabilities.The vaccine industry is an essential pillar of public health with high entry barriers, stringent oversight, and extended development cycles – all factors contributing to its significant growth potential. As a leading domestic vaccine producer, Kanghua Biological's flagship product - human diploid cell rabies vaccine – stands as China's first domestically developed premium vaccine with over a decade of safe application, established market presence and nationwide distribution. The Company also maintains a robust global innovation pipeline, having successfully licensed its recombinant hexavalent norovirus vaccine overseas. This strategic acquisition, focused on critical segments of the vaccine value chain, will strengthen its strategic positioning. The M&A Fund is committed to supporting Kanghua Biological in leveraging its core product line while harnessing the combined strengthens of Shanghai and Chengdu to accelerate the formation of a next-generation vaccine industry ecosystem.This acquisition marks a significant step to drive Shanghai and Chengdu biopharmaceutical cooperation. Post-transaction, Kanghua Biological will capitalize on Shanghai's advanced R&D resources and access to top-tier scientific talent and global capital to enhances its industrial capabilities, manufacturing capacity, and market penetration. The M&A Fund will consolidate diverse industrial assets to promote Kanghua Biological's integration with Shanghai's R&D and clinical networks, creating an end-to-end collaborative system that spans from "clinical R&D to commercialization" and accelerates the development of a full industrial value chain."This transaction goes beyond a typical corporate acquisition, it represents a transformative catalyst for industrial upgrading,""This exemplifies the complementary strengths created by resource-empowered consolidation. With deep biopharmaceutical, financial, R&D, and global network expertise, Shanghai Healthcare M&A Fund will create significant synergies with Kanghua Biological's technologies, products, manufacturing, and domestic distribution to have an outsized impact on the sector."Hashtag: #SIICCapital #ChengduKanghuaBiological #ShanghaiHealthcareM&AFund
The issuer is solely responsible for the content of this announcement.
About Shanghai Healthcare M&A Fund
A core component of Shanghai's state-owned capital fund network, Shanghai Healthcare M&A Fund is managed by SIIC Capital, a subsidiary of SIIC Group. The M&A Fund targets Shanghai's biopharmaceutical sector, aligning government policy objectives with industrial needs by fostering collaboration with leading industry companies, strengthening sector clusters, and enabling asset restructuring. Through capital infusion, improving governance, optimizing management, and executing M&A, the M&A Fund backs "anchor" companies to build complementary and reinforcing links in the value chain, driving the ongoing transformation of specialized subsectors.
About Chengdu Kanghua Biological Products Co., Ltd.
Chengdu Kanghua Biological Products Co., Ltd. is a biopharmaceutical company engaged in research, manufacture and commercialization of biological products. Established in 2004, the company operates an in-house testing center and GMP-certified bacterial and viral vaccine production facilities. Its marketed portfolio includes the ACYW135 meningococcal polysaccharide vaccine and a freeze-dried human diploid cell rabies vaccine. Kanghua holds GMP certification from China's National Medical Products Administration, has participated in numerous scientific research projects and has been granted patents for over 100 technologies.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Free Malaysia Today
2 hours ago
- Free Malaysia Today
Laws needed as more AI is used in healthcare, says private hospitals group
Government clinics have managed to cut patient wait times with the help of AI. PETALING JAYA : A private healthcare interest group has called for laws to govern the use of artificial intelligence (AI) in healthcare, saying it could result in serious risks if left unchecked. Association of Private Hospitals Malaysia president Dr Kuljit Singh said without proper regulation, the technology could risk patient data and lead to misuse. He said AI was already being used in private hospitals for scans, surgeries, and even patient registration. 'As AI is integrated into healthcare, it is vital that safeguards are first established. 'Strong regulatory frameworks must be in place to prevent data breaches and ensure responsible use by all parties,' he said in a statement. Kuljit also called for a national body to oversee the use of health data and ensure that AI tools are tested for safety and fairness before being used. He said the lack of such oversight could open the door to cyberattacks or flawed decisions based on bad data. Separately, he praised the government's decision to roll out AI tools in public health clinics, such as using the technology to cut patient wait times. He said with AI, the health ministry had managed to reduce wait times to under 30 minutes following its implementation at 56 clinics nationwide. Kuljit also said the government's use of AI-backed centralised medical records systems allowed it to easily handle millions of prescriptions and vaccination logs. He said there should be more sharing of such data, including research between public and private hospitals under secure systems to help AI tools learn and improve. 'If we get this right, we can expect to reap the benefits of AI in the next three to five years,' he said.
Malay Mail
3 hours ago
- Malay Mail
China premier: AI is a ‘tiger cub' that needs taming before it turns on us
SHANGHAI, July 26 — China's Premier Li Qiang warned today that artificial intelligence development must be weighed against the security risks, saying global consensus was urgently needed even as the tech race between Beijing and Washington shows no sign of abating. His remarks came just days after US President Donald Trump unveiled an aggressive low-regulation strategy aimed at cementing US dominance in the fast-moving field, promising to 'remove red tape and onerous regulation' that could hinder private sector AI development. Opening the World AI Conference (WAIC) in Shanghai today, Li emphasised the need for governance and open-source development, announcing the establishment of a Chinese-led body for international AI cooperation. 'The risks and challenges brought by artificial intelligence have drawn widespread attention... How to find a balance between development and security urgently requires further consensus from the entire society,' the premier said. Li said China would 'actively promote' the development of open-source AI, adding Beijing was willing to share advances with other countries, particularly developing ones. 'If we engage in technological monopolies, controls and blockage, artificial intelligence will become the preserve of a few countries and a few enterprises,' he said. 'Only by adhering to openness, sharing and fairness in access to intelligence can more countries and groups benefit from (AI).' The premier highlighted 'insufficient supply of computing power and chips' as a bottleneck. Washington has expanded its efforts in recent years to curb exports of state-of-the-art chips to China, concerned that these can be used to advance Beijing's military systems and erode US tech dominance. For its part, China has made AI a pillar of its plans for technological self-reliance, with the government pledging a raft of measures to boost the sector. In January, Chinese startup DeepSeek unveiled an AI model that performed as well as top US systems despite using less powerful chips. 'Pet tiger cub' At a time when AI is being integrated across virtually all industries, its uses have raised major ethical questions, from the spread of misinformation to its impact on employment, or the potential loss of technological control. In a speech at WAIC today, Nobel Prize-winning physicist Geoffrey Hinton compared the situation to keeping 'a very cute tiger cub as a pet'. 'To survive', he said, you need to ensure you can train it not to kill you when it grows up. In a video message played at the WAIC opening ceremony, UN Secretary-General Antonio Guterres said AI governance would be 'a defining test of international cooperation'. The ceremony also saw the French president's AI envoy, Anne Bouverot, underscore the 'an urgent need' for global action. At an AI summit in Paris in February, 58 countries including China, France and India — as well as the European Union and African Union Commission — called for enhanced coordination on AI governance. But the United States warned against 'excessive regulation', and alongside the United Kingdom, refused to sign the summit's appeal for an 'open', 'inclusive' and 'ethical' AI. — AFP
The Star
4 hours ago
- The Star
China must strike a delicate balance in its approach towards Thai-Cambodian conflict, say analysts
CHONGQING, (China): China faces a delicate balancing act as it decides what role it should play in the ongoing border hostilities between Thailand and Cambodia, two South-east Asian nations that are its close neighbours and which it wields strong influence over. Analysts told The Straits Times that while the clash, which began on Thursday (July 24) and has so far reportedly left at least 16 dead, could present an opportunity for China to showcase its leadership in the region, the world's second-largest economy is likely to keep to its traditional approach of having the two countries resolve the matter on their own. It is also likely to first look to Asean as it assesses how it can best help the process along. But that does not mean that China will not attempt to bring both countries to the negotiating table as the conflict is happening in its neighbourhood, said Professor Fan Lei, an expert on China-Asean relations at China's Charhar Institute, an international relations think-tank. Asean is China's largest trading partner, representing 16.6 per cent of the world's second-largest economy's overall foreign trade. Total trade between Asean and China reached 1.71 trillion yuan (S$305 billion) in 2024, up 7.1 per cent from 2023. Analysts pointed to how China can play a bigger role in the dispute between Thailand and Cambodia, given that China is both countries' top trading partner and thus wields strong economic influence over both states. Thailand relies on Chinese imports such as machinery, electronics and vehicles. China is also Thailand's top source of foreign tourists. Meanwhile, bilateral trade between Cambodia and China grew 26.9 per cent in the first six months of 2025, compared with the same period in 2024, official data from Cambodia showed. China is a major investor in both Thailand and Cambodia in sectors such as electric vehicles, infrastructure and real estate. It also conducts separate military exercises with Cambodia and Thailand. In April, Chinese-sponsored upgrades to Ream Naval Base in Cambodia raised concerns about China's growing footprint in South-east Asia. But China has to tread a delicate balance. On the one hand, 'China may feel that it should not just sit idly by and do nothing if such military conflict is in its neighbourhood', said Associate Professor Li Mingjiang, an expert on Chinese foreign policy and regional security at the S. Rajaratnam School of International Studies. On the other hand, it has to be mindful not to 'leave the impression it is disregarding Asean', said Professor Zhu Feng, dean at the School of International Studies at Nanjing University. Already, countries in South-east Asia are wary of China's expanding influence in the region – and its clashes with the Philippines over maritime territorial claims – as they navigate an increasingly complex geopolitical landscape amid intense US-China rivalry. That is why China is most likely to conduct 'quiet and informal mediation', Prof Li said, adding that he believes 'Chinese diplomats may already be involved in discussions with Cambodia and Thailand, urging them to de-escalate and engage in talks'. Professor Gu Jiayun, vice-dean at the School of Asian Studies at Beijing Foreign Studies University, said: 'It is in China's interest to keep the peace among its neighbours, given that conflict can hurt the region's as well as its own development prospects.' Prof Gu said that both Thailand and Cambodia have 'shown restraint in the clash so far, so they might be looking for an out to start negotiations'. Publicly, Thailand has rejected mediation efforts from third countries to end the ongoing conflict. However, it has signalled that the door will be kept open for Asean to facilitate a return to bilateral negotiations with Cambodia. Phnom Penh has written to the United Nations for help – the first time in more than a decade that an Asean member state has made such a request. The latest border dispute escalated sharply on July 24 after a Thai F-16 fighter jet bombed targets in Cambodia that day. Tensions between Thailand and Cambodia have been steaming since May, when a Cambodian soldier was killed during a brief exchange of gunfire near the border in north-eastern Thailand. Both countries – which share a long history of border disputes that date back to France's occupation of Cambodia until 1953 – have blamed each other for the latest escalation, and downgraded their diplomatic ties on July 23. During a meeting between Chinese Foreign Minister Wang Yi and Asean secretary-general Kao Kim Hourn in Beijing on July 25, Wang said that China 'stands ready to continue playing a constructive role in easing tensions (between Thailand and Cambodia) and de-escalating the situation in an impartial and fair manner'. Calling the latest deadly clash 'distressing and concerning', Wang added: 'China appreciates and supports the proactive mediation efforts of the Asean Chair and encourages the 'Asean Way' to promote dialogue and political resolution.' Asean's fundamental principles include mutual respect for the sovereignty of all nations, non-interference in the internal affairs of member states, peaceful settlement of disputes, and renunciation of the threat or use of force. On July 24, a Chinese Foreign Ministry spokesman told reporters at a regular briefing that 'China has and will continue to promote talks (between the two Asean states) for peace in its own way, and play a constructive role in promoting de-escalation'. Prof Fan said that China is likely to draw Cambodia and Thailand into negotiations with economic ways. This would be in line with the Chinese government's emphasis on cooperative win-win partnerships and non-interference principles regarding foreign diplomacy that are part of China's Three Global Initiatives, he added. 'It is also a possibility that China might encourage Thailand and Cambodia to resolve their dispute at Hong Kong's new international mediation body,' Prof Fan said. China signed on May 30 a convention to set up an international organisation for mediation in Hong Kong to resolve cross-border disputes among countries and international companies that Beijing hopes can match up to the UN's International Court of Justice. Analysts noted that China's actions will be a test of its diplomatic strength in the region. Prof Li said China has been signalling that 'it does want to gradually play a slightly larger role in the region' that goes beyond traditional security issues. Chinese President Xi Jinping's first overseas trip in 2025 amid growing trade tensions with the US was to South-east Asia, where he visited Malaysia, Cambodia and Vietnam for a week in April. Prof Li said: 'The conflict between Cambodia and Thailand could be an opportunity for China to try out its limited role so far in addressing the security issues in the Mekong region, cautiously, quietly and informally, of course.' - The Straits Times/ANN
